Dr. Hartion discusses AI’s Future in the Embryo Transfer Process
Artificial intelligence (AI) is beginning to learn how to choose the most viable embryo to be transferred during in vitro fertilization (IVF). Dr. Eduardo Hariton, a reproductive endocrinologist with RSC Bay Area, is highly motivated by the possibilities this innovative technology offers fertility patients.
“Price is one reason this is an area of interest,” says Dr. Hariton. “More meds mean more money, and ovarian-stimulating hormones can cost $2,000-$5,000 per cycle.” AI tools could be used to detect high quality embryos without requiring a biopsy or genetic testing, potentially saving fertility patients thousands of dollars.
AI could also speed up the selection portion of the embryo transfer process, allowing reproductive endocrinologists to treat more patients in less time. “The reality is when you have an access issue … and you’re trying to make sure that you can get more patients in, this is an efficiency tool,” says Dr. Hariton.